Overview
Benjamin Mckinney is an Intensive Care Medicine specialist and an Infectious Disease provider in Glen Burnie, Maryland. Dr. Mckinney has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Kaposi Sarcoma. His top area of expertise is Kaposi Sarcoma.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Kaposi Sarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Locations
1406 Crain S Hwy 106, Glen Burnie, MD 21061
110 Irving St Nw, Washington, DC 20010
3001 S Hanover St, Baltimore, MD 21225
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Eric Engels is an Infectious Disease provider in Baltimore, Maryland. Dr. Engels is rated as an Advanced provider by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are Kaposi Sarcoma, HIV/AIDS, Hepatitis, and Mononucleosis.
Irini Sereti is an Infectious Disease provider in Bethesda, Maryland. Dr. Sereti is rated as a Distinguished provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are HIV/AIDS, Kaposi Sarcoma, Sepsis, Mycobacterium Avium Complex Infections, and Colonoscopy.
The Johns Hopkins Hospital
Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as a Distinguished provider by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers